Calvert Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Calvert Investment Management's BMY Position: Q1 2017 in Review
Calvert Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 105,620 shares — an estimated $6.17M sold.
Calvert Investment Management first reported a position in BMY in Q2 2013 and held it in 15 quarters. The position peaked at $10.7M in Q2 2015. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- Calvert Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
- Calvert Investment Management sold 105,620 Bristol-Myers Squibb shares in Q1 2017, an estimated $6.17M.
- Calvert Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 15 quarters.
- Calvert Investment Management's Bristol-Myers Squibb position peaked at $10.7M in Q2 2015.
- 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on Calvert Investment Management's 13F filing for Q1 2017.